Publicaciones en las que colabora con Pablo Garrido Gil (9)

2009

  1. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not elicit long-lasting increases in cyclooxygenase-2 expression in dopaminergic neurons of monkeys

    Journal of Neuropathology and Experimental Neurology, Vol. 68, Núm. 1, pp. 26-36

  2. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys

    Journal of Neuroscience Research, Vol. 87, Núm. 2, pp. 586-597

  3. Acute and chronic 1-Methyl-4-Phenyl-1,2,3,6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys

    Journal of Neuropathology and Experimental Neurology, Vol. 68, Núm. 9, pp. 977-984

  4. Mecanismos de degeneración neuronal dopaminérgica inducidos por la administración subaguda y crónica de MPTP a monos Cynomolgus

    Mecanismos de degeneración neuronal dopaminérgica inducidos por la administración subaguda y crónica de MPTP a monos Cynomolgus

2008

  1. Immunohistochemical characterization of the rat carotid body

    Respiratory Physiology and Neurobiology, Vol. 161, Núm. 1, pp. 95-99

  2. Striatal carotid body graft promotes differentiation of neural progenitor cells into neurons in the olfactory bulb of adult hemiparkisonian rats

    Brain Research, Vol. 1217, pp. 213-220

2007

  1. Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft

    Brain, Vol. 130, Núm. 5, pp. 1306-1316

  2. The number of dopaminergic cells is increased in the olfactory bulb of monkeys chronically exposed to MPTP

    Synapse, Vol. 61, Núm. 12, pp. 1006-1012

2006

  1. Does increased excitatory drive from the subthalamic nucleus contribute to dopaminergic neuronal death in Parkinson's disease?

    Experimental Neurology, Vol. 201, Núm. 2, pp. 407-415